Generation of novel bone forming cells (Monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Zhang, Zhifang ^a   Shively, John E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BONE SIALOPROTEIN; BONE SIALOPROTEIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHEPSIN K; GELATINASE B; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEONECTIN; OSTEOPONTIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CYTOKINE;

ARTICLE; BONE REMODELING; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MESENCHYMAL STEM CELL; MONOCYTE; MONOOSTEOPHIL; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCANNING ELECTRON MICROSCOPY; TISSUE INJURY; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; OSTEOCYTE; PHASE CONTRAST MICROSCOPY; TIME; ULTRASTRUCTURE;

MUS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, PHASE-CONTRAST; MONOCYTES; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS; OSTEONECTIN; TIME FACTORS;

EID: 78649742040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013985     Document Type: Article

References (59)

1. Nuttall ME, Gimble JM (2004) Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4: 290-294.
2. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
3. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanismsand implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137.
4. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC (1998) Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13: 793-802.
5. Khosla S, Westendorf JJ, Oursler MJ (2008) Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118: 421-428.
6. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood ''endothelial progenitor cells'' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
7. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, et al. (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516.
8. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, et al. (2001) Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 49: 671-680.
9. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, et al. (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65: 287-300.
10. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, et al. (2003) Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74: 833-845.
11. Zhao Y, Glesne D, Huberman E (2003) A human peripheral blood monocytederived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100: 2426-2431.
12. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, et al. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192: 1069-1074.
13. Zhang Z, Cherryholmes G, Chang F, Rose DM, Schraufstatter I, et al. (2009) Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol 39: 3181-3194.
14. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, et al. (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172: 1146-1156.
15. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N (1997) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90: 2796-2803.
16. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, et al. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170: 5583-5589.
17. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111: 1665-1672.
18. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, et al. (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171: 6690-6696.
19. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, et al. (2003) Thecathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120: 379-389.
20. Agerberth B, Charo J, Werr J, Olsson B, Idali F, et al. (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96: 3086-3093.
21. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, et al. (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106: 20-26.
22. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 169: 3883-3891.
23. Zhang Z, Cherryholmes G, Shively JE (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 84: 780-788.
24. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, et al. (1995) The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95: 1207-1216.
25. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC (1999) Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells. J Leukoc Biol 65: 232-240.
26. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565.
27. Tosello V, Zamarchi R, Merlo A, Gorza M, Piovan E, et al. (2009) Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4. Eur J Immunol 39: 56-66.
28. Sorensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, et al. (2007) Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 25: 36-45.
29. Isenmann S, Arthur A, Zannettino AC, Turner JL, Shi S, et al. (2009) TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27: 2457-2468.
30. Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, et al. (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233: 1171-1180.
31. Yuasa K, Mori K, Ishikawa H, Sudo A, Uchida A, et al. (2007) Characterization of two types of osteoclasts from human peripheral blood monocytes. Biochem Biophys Res Commun 356: 354-360.
32. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273: 3718-3724.
33. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289: 1504-1508.
34. Shapiro F (2008) Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15: 53-76.
35. Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, et al. (2009) Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Am J Physiol Endocrinol Metab 297: E1339-1348.
36. Gordon S (1995) The macrophage. Bioessays 17: 977-986.
37. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, et al. (2001) Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
38. Servet-Delprat C, Arnaud S, Jurdic P, Nataf S, Grasset MF, et al. (2002) Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells andmicroglia. BMC Immunol 3: 15.
39. Naito M, Hasegawa G, Takahashi K (1997) Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 39: 350-364.
40. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
41. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, et al. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196: 137-151.
42. Zhou LJ, Tedder TF (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93: 2588-2592.
43. Puig-Kroger A, Sanz-Rodriguez F, Longo N, Sanchez-Mateos P, Botella L, et al. (2000) Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J Immunol 165: 4338-4345.
44. Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM (2000) Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem 48: 219-228.
45. Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast developmentand function. Nat Rev Genet 4: 638-649.
46. Ducy P, Schinke T, Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504.
47. Franc NC, Dimarcq JL, Lagueux M, Hoffmann J, Ezekowitz RA (1996) Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity 4: 431-443.
48. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11: 753-761.
49. Waskow C, Liu K, Darrasse-Jeze G, Guermonprez P, Ginhoux F, et al. (2008) The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 9: 676-683.
50. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
51. Kandler K, Shaykhiev R, Kleemann P, Klescz F, Lohoff M, et al. (2006) The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol 18: 1729-1736.
52. Bandholtz L, Ekman GJ, Vilhelmsson M, Buentke E, Agerberth B, et al. (2006) Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype. Scand J Immunol 63: 410-419.
53. van der Does AM, Beekhuizen H, Ravensbergen B, Vos T, Ottenhoff TH, et al. LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J Immunol 185: 1442-1449.
54. Sorensen O, Bratt T, Johnsen AH, Madsen MT, Borregaard N (1999) The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J Biol Chem. pp 22445-22451.
55. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
56. Schaller-Bals S, Schulze A, Bals R (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165: 992-995.
57. Malm J, Sorensen O, Persson T, Frohm-Nilsson M, Johansson B, et al. (2000) The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun 68: 4297-4302.
58. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, et al. (2002) Endogenousantimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151-1160.
59. Frohm M, Gunne H, Bergman AC, Agerberth B, Bergman T, et al. (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237: 86-92.